Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Tergene Biotech Limited, is an unlisted public company incorporated on 07 March, 2008. It is classified as a public limited company and is located in Rangareddi, Telangana. It's authorized share capital is INR 46.00 cr and the total paid-up capital is INR 44.95 cr.
Tergene Biotech Limited's operating revenue range is Under INR 1 cr for the financial year ending on 31 March, 2023.
Read more
** All rupee values in INR lacs. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Mosuvan Kuppusamy
Shareholder
|
00066698 | 17 years |
Director | Sivakumaran Meenakshisunderam | 01284320 | 10 years |
Whole-time Director | Sathyan Kuppusamy
Shareholder
|
01493015 | 17 years |
Director | Santhanam Subramanian | 03516515 | 9 years |
Director | Umesh Krishnamoorthy | 10195095 | 2 years |
Kmp | Vijayudu Gajulapalli | <HIDDEN> | 1 years |
CFO | Lonkari Sudhakar | <HIDDEN> | 3 years |
Kmp | Kumar Janmejay | <HIDDEN> | 1 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 1 | Telangana |
APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 1 | Telangana |
CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 1 | Telangana |
AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 1 | Telangana |
AUROACTIVE PHARMA PRIVATE LIMITED |
Active
|
100.0 Cr | 2 | Telangana |
AURO PEPTIDES LIMITED |
Active
|
265.9 Cr | 1 | Telangana |
AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 1 | Telangana |
EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 2 | Telangana |
CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
APL HEALTHCARE LIMITED |
Active
|
216.0 Cr | 1 | |
SAMIES TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.5 L | 1 | Tamil Nadu |
THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 1 | Telangana |
EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 1 | Telangana |
LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
EUGIA PHARMA SPECIALITIES LIMITED |
Active
|
621.0 Cr | 1 |
Read more
The incorporation date of TERGENE BIOTECH LIMITED is 07 March, 2008
The authorized share capital of TERGENE BIOTECH LIMITED is INR ₹ 46.0 Cr.
The paid-up capital of TERGENE BIOTECH LIMITED is INR ₹ 45.0 Cr.
The registered address of TERGENE BIOTECH LIMITED is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderaba d Knowledge City, Raidurg Panmak tha NA Hyderabad Rangareddi Telangana - 500032
The CIN number of TERGENE BIOTECH LIMITED is U24230TG2008PLC113178.